The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Gaza death toll hits 60,000 as global monitor demands action to avert famine
Gunman kills four in Manhattan skyscraper, then takes own life
India says forces killed 3 'terrorists' behind Kashmir attack
GCC welcomes efforts for two-state solution amid Saudi-French conference
Thailand-Cambodia border calm as military commanders hold talks
Trump says many are starving in Gaza, vows to set up food centres
Extreme weather turns Beijing into rain trap, kills at least 30
Two Israeli rights groups accuse Israel of genocide
